Xunliang Li
Overview
Explore the profile of Xunliang Li including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
198
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zhu J, Shi R, Li X, Liu M, Yu L, Bai Y, et al.
BMC Nephrol
. 2025 Mar;
26(1):112.
PMID: 40038629
Background: The neutrophil percentage-to-albumin ratio (NPAR) emerges as a novel inflammation marker, demonstrating prognostic ability in a variety of cardiovascular diseases. However, its impact on mortality among patients undergoing maintenance...
2.
Li X, Liu M, Ye Q, Zhu J, Zhao W, Pan H, et al.
Ren Fail
. 2025 Feb;
47(1):2448261.
PMID: 39894937
Background: Obesity is a recognized risk factor for chronic kidney disease (CKD), but whether weight change is associated with CKD remains unclear. This research aimed to investigate the relationship between...
3.
Liu M, Zhao W, Shi R, Wang Z, Li X, Wang D
BMC Pharmacol Toxicol
. 2025 Jan;
26(1):17.
PMID: 39871379
Background: Renal fibrosis is crucial in the progression of chronic kidney disease (CKD) to end-stage renal failure. Geniposide, an iridoid glycoside, has shown therapeutic potential in acute kidney injury, diabetic...
4.
Li X, Zhao W, Pan H, Wang D
J Obes Metab Syndr
. 2025 Jan;
34(1):65-74.
PMID: 39800332
Background: Whether there is a causal relationship between childhood obesity and increased risk of chronic kidney disease (CKD) remains controversial. This study sought to explore how body size in childhood...
5.
Li X, Zhao C, Liu M, Zhao W, Pan H, Wang D
Arch Public Health
. 2025 Jan;
83(1):2.
PMID: 39780273
Background: This study aims to assess the global burden and trends in cardiovascular diseases (CVDs) prevalence, stratified by sociodemographic index (SDI) categories and age groups, across 204 countries and territories....
6.
Zhao L, Zhang T, Li X, Chen L, Zhou S, Meng Z, et al.
J Inflamm Res
. 2024 Sep;
17:5653-5662.
PMID: 39219815
Purpose: Sepsis-associated acute kidney injury (S-AKI) is associated with increased morbidity and mortality. We aimed to develop a nomogram for predicting the risk of S-AKI patients. Patients And Methods: We...
7.
Zu S, Yang M, Li X, Wu H, Li X, Fan Y, et al.
Front Nutr
. 2024 Jul;
11:1400726.
PMID: 38957872
This study conducted data on 15,446 adults to explore the impact of flavonoids on weight-adjusted waist index (WWI). This was a nationwide cross-sectional study among US adults aged 20 years...
8.
Li X, Wang P, Zhu Y, Zhao W, Pan H, Wang D
BMC Med Inform Decis Mak
. 2024 May;
24(1):148.
PMID: 38822285
Background: This study aimed to create a method for promptly predicting acute kidney injury (AKI) in intensive care patients by applying interpretable, explainable artificial intelligence techniques. Methods: Population data regarding...
9.
Li X, Li X, Zhao W, Wang D
BMC Nephrol
. 2024 May;
25(1):175.
PMID: 38773418
Background: The purpose of this study was to develop a nomogram for predicting in-hospital mortality in cirrhotic patients with acute kidney injury (AKI) in order to identify patients with a...
10.
Wang Z, Wei J, Zhao W, Shi R, Zhu Y, Li X, et al.
Lipids Health Dis
. 2024 Mar;
23(1):84.
PMID: 38509588
Background: Sodium-glucose cotransporter 2 (SGLT2) inhibition is recognized for its evident renoprotective benefits in diabetic renal disease. Recent data suggest that SGLT2 inhibition also slows down kidney disease progression and...